Lifeblood Consulting Group is a specialized organizational consulting firm that focuses on people - the lifeblood of every organization. Monica Weil founded the group in 2002, after 20+ years as a successful organizational consultant and human resources executive with international experience. Ms Weil's expertise in this area covers various science, technology, and consumer products industries.

We are committed to accelerating our clients' success through people. Our market is primarily biotech and pharmaceutical organizations, though we also work with other industries.

By helping our client-partners look at their business processes differently, we enable them to identify innovative approaches and communicate effectively to diverse audiences.

A particular strength of Lifeblood Consulting is working cross-culturally. Ms. Weil has extensive international experience.

In one assignment, she designed and facilitated an off-site retreat for the European management team of a major biotech firm. She successfully met her goal of improving this group's dynamic, enabling them to work together more productively. Additionally, Ms. Weil managed a high-level meeting between two groups - one from London and one from Paris - in order to establish better coordination between them. Her success with such cross-cultural team members illustrates her expertise at getting people to look beyond cultural differences and work together more peaceably. Client organizations benefit time and again from her involvement at this level. International experience is a major asset in today's business world. Firms are global. Team members come from many different backgrounds and cultures. Lifeblood Consulting Group has a history of developing innovative solutions within multicultural organizations, by focusing on how to make a firm's human resources more effective and productive.

“Monica’s style is very successful with the typical company achiever who doesn't want to waste any time... she got right into the matter... and helped us to create solutions.”

                                                                 Gunther Winkler,
                                                                 Vice President,
                                                                 Stategic Initiatives Biogen Idec